Rocket


Overview
Financials
News + Filings

 
 

Relay Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-19Dec-31-18
Revenues0.00.0
Cost of goods sold0.00.0
Gross profit0.00.0
Research and development70.341.0
General and administrative13.78.9
EBIT-84.0-49.9
Pre-tax income-75.3-48.8
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-75.3-48.8
 
Diluted EPS($6.15)($5.53)
Shares outstanding (diluted)12.38.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy